<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="4.3.2">Jekyll</generator><link href="https://rokitalab.com/feed.xml" rel="self" type="application/atom+xml" /><link href="https://rokitalab.com/" rel="alternate" type="text/html" /><updated>2026-02-18T20:23:14+00:00</updated><id>https://rokitalab.com/feed.xml</id><title type="html">The Rokita Lab</title><entry><title type="html">Bailey Farrow joins the BTI Bioinformatics Core Leadership!</title><link href="https://rokitalab.com/2026/02/17/welcome-bailey.html" rel="alternate" type="text/html" title="Bailey Farrow joins the BTI Bioinformatics Core Leadership!" /><published>2026-02-17T00:00:00+00:00</published><updated>2026-02-18T20:22:24+00:00</updated><id>https://rokitalab.com/2026/02/17/welcome-bailey</id><content type="html" xml:base="https://rokitalab.com/2026/02/17/welcome-bailey.html"><![CDATA[<p>We are thrilled to welcome Bailey Farrow to Children‚Äôs National Hospital (CNH) as our new Senior Bioinformatics Program and Operations Manager for the Brain Tumor Institute (BTI) Bioinformatics Core! üéâ</p>

<p>Bailey brings more than a decade of experience leading complex data platforms, technical teams, and multi-institutional research initiatives across academic medicine and industry. 
Most recently, she served as Program Director for pediatric epilepsy initiatives at the University of Chicago‚Äôs Data for the Common Good, where she led large-scale, multi-institutional data-sharing initiatives spanning clinicians, researchers, patient advocacy organizations, and major philanthropic partners, including the Chan Zuckerberg Initiative.
Her work focused on building an epilepsy data commons by aligning diverse stakeholders and integrating multimodal data, including EEG, EHR, genomics, and patient-reported outcomes, into a scalable shared infrastructure. In parallel, she helped lead the development of an ethical framework for the responsible use of pediatric data in multimodal AI, operationalized through the creation of a lived-experience stakeholder engagement panel.</p>

<p>Prior to her work at Chicago, Bailey spent over six years at the Children‚Äôs Hospital of Philadelphia (CHOP) in the Center for Data-Driven Discovery in Biomedicine (D3b), where she led data operations for the NIH Common Fund‚Äôs Gabriella Miller Kids First Pediatric Research Program and the Children‚Äôs Brain Tumor Network. 
This included large-scale genomic sequencing initiatives and development of cloud-based research platforms supporting tens of thousands of subjects nationwide. 
Her leadership in building data operations teams, modernizing support workflows, architecting next-generation data platforms, and managing multi-million-dollar cloud and federal grant budgets resulted in efficiency gains and long-term sustainability for complex pediatric research programs.</p>

<p>Bailey‚Äôs career reflects a rare combination of deep technical fluency, strategic program management, and people-centered leadership. 
She has built and led cross-functional teams across engineering, data science, quality assurance, operations, and regulatory domains‚Äîalways with a focus on scalability, clarity, and impact.</p>

<p>We are incredibly excited to have Bailey‚Äôs expertise guiding our bioinformatics program strategy, data operations, and infrastructure development at CNH. 
Her experience scaling national research data ecosystems will be instrumental as we continue advancing precision medicine for pediatric oncology.</p>

<p>Welcome to the team, Bailey! üëè</p>]]></content><author><name>Jo Lynne Rokita</name></author><category term="team" /><summary type="html"><![CDATA[We are thrilled to welcome Bailey Farrow to Children‚Äôs National Hospital (CNH) as our new Senior Bioinformatics Program and Operations Manager for the Brain Tumor Institute (BTI) Bioinformatics Core! üéâ]]></summary></entry><entry><title type="html">Jacob White joins the Rokita Lab!</title><link href="https://rokitalab.com/2026/01/06/welcome-jacob.html" rel="alternate" type="text/html" title="Jacob White joins the Rokita Lab!" /><published>2026-01-06T00:00:00+00:00</published><updated>2026-02-18T20:22:24+00:00</updated><id>https://rokitalab.com/2026/01/06/welcome-jacob</id><content type="html" xml:base="https://rokitalab.com/2026/01/06/welcome-jacob.html"><![CDATA[<p>We are excited to welcome masters student, Jacob White, to the Rokita Lab at Children‚Äôs National Hospital (CNH) üéâ.
Jacob will begin his research by studying both mechanisms of RNA splicing in pediatric brain tumors and identifying tractable splice-derived therapeutic targets.</p>

<p>Jacob is passionate about using multi-omics data to improve therapeutics.</p>

<p>Welcome, Jacob! üëè</p>]]></content><author><name>Jo Lynne Rokita</name></author><category term="team" /><summary type="html"><![CDATA[We are excited to welcome masters student, Jacob White, to the Rokita Lab at Children‚Äôs National Hospital (CNH) üéâ. Jacob will begin his research by studying both mechanisms of RNA splicing in pediatric brain tumors and identifying tractable splice-derived therapeutic targets.]]></summary></entry><entry><title type="html">Vinay Gujjula joins the Rokita Lab!</title><link href="https://rokitalab.com/2026/01/06/welcome-vinay.html" rel="alternate" type="text/html" title="Vinay Gujjula joins the Rokita Lab!" /><published>2026-01-06T00:00:00+00:00</published><updated>2026-02-18T20:22:24+00:00</updated><id>https://rokitalab.com/2026/01/06/welcome-vinay</id><content type="html" xml:base="https://rokitalab.com/2026/01/06/welcome-vinay.html"><![CDATA[<p>We are excited to welcome masters student, Vinay Gujjula, to the Rokita Lab at Children‚Äôs National Hospital (CNH) üéâ.
Vinay will begin his research by investigating the inheritance of pathogenic or likely pathogenic germline variants in pediatric brain tumors.</p>

<p>Vinay is passionate about exploring the effects of genetic ancestry on tumor development.</p>

<p>Welcome, Vinay! üëè</p>]]></content><author><name>Jo Lynne Rokita</name></author><category term="team" /><summary type="html"><![CDATA[We are excited to welcome masters student, Vinay Gujjula, to the Rokita Lab at Children‚Äôs National Hospital (CNH) üéâ. Vinay will begin his research by investigating the inheritance of pathogenic or likely pathogenic germline variants in pediatric brain tumors.]]></summary></entry><entry><title type="html">Our integrative analysis of PBTA host-tumor genomes has been published in Nature Communications!</title><link href="https://rokitalab.com/2025/11/21/corbett-germline-paper-accepted.html" rel="alternate" type="text/html" title="Our integrative analysis of PBTA host-tumor genomes has been published in Nature Communications!" /><published>2025-11-21T00:00:00+00:00</published><updated>2026-02-18T20:22:24+00:00</updated><id>https://rokitalab.com/2025/11/21/corbett-germline-paper-accepted</id><content type="html" xml:base="https://rokitalab.com/2025/11/21/corbett-germline-paper-accepted.html"><![CDATA[<p>We‚Äôre thrilled to share the publication of our latest study, ‚ÄúGermline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors,‚Äù now out in <a href="https://www.nature.com/articles/s41467-025-65190-4">Nature Communications</a>. Led by <a href="https://rokitalab.com/members/02-ryan-corbett.html">Dr. Ryan Corbett</a> in the Rokita Lab, this work represents a comprehensive multi-omic analysis of germline and somatic data from 830 pediatric brain tumor patients in the #PBTA ‚Äî truly a <em>tour de force</em> by the team.</p>

<p>We highlight the importance of germline testing at diagnosis, identifying rare germline pathogenic (P) or likely pathogenic (LP) variants in 48 patients (5.7%) who had no clinically reported cancer predisposition syndrome. 
Among all P/LP carriers, 34.6% had putative somatic second hits or loss-of-function tumor alterations, consistent with classical tumor suppressor models.
We link germline P/LP variation with somatic events, tumor histologies, molecular subtypes, and clinical outcomes ‚Äî with some variants associated with protection and others with poorer survival.
Together, these findings deepen our understanding of how inherited or early-life genetic changes shape pediatric CNS tumor development, behavior, and outcomes. 
They pave the way for improved diagnosis, risk stratification, monitoring, and targeted therapy.</p>

<p>üôè Enormous thanks to our collaborators Children‚Äôs Hospital of Philadelphia ‚Äî especially my partner-in-crime Sharon Diskin and co-first author Rebecca Kaufman. 
Thank you to our clinical experts whose insights into gene lists and variant curation were invaluable: Miriam Bornhorst, Suzanne MacFarland, Kristina Cole, and Shelly McQuaid.</p>

<p>Special thanks to the patients and families, the Children‚Äôs Brain Tumor Network for creating this dataset, the anonymous donors to the Brain Tumor Institute, Gabriella Miller Kids First Data Resource Center for supporting us with cloud credits, and every member of the team whose dedication made this possible.</p>

<p>Read the Children‚Äôs National press release <a href="https://innovationdistrict.childrensnational.org/new-insights-into-genetics-of-childhood-brain-and-spinal-tumors/">here</a>.</p>]]></content><author><name>Jo Lynne Rokita</name></author><category term="publication" /><summary type="html"><![CDATA[We‚Äôre thrilled to share the publication of our latest study, ‚ÄúGermline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors,‚Äù now out in Nature Communications. Led by Dr. Ryan Corbett in the Rokita Lab, this work represents a comprehensive multi-omic analysis of germline and somatic data from 830 pediatric brain tumor patients in the #PBTA ‚Äî truly a tour de force by the team.]]></summary></entry><entry><title type="html">Dr. Meghali Goswami joins the Rokita Lab!</title><link href="https://rokitalab.com/2025/10/13/welcome-meg.html" rel="alternate" type="text/html" title="Dr. Meghali Goswami joins the Rokita Lab!" /><published>2025-10-13T00:00:00+00:00</published><updated>2026-02-18T20:22:24+00:00</updated><id>https://rokitalab.com/2025/10/13/welcome-meg</id><content type="html" xml:base="https://rokitalab.com/2025/10/13/welcome-meg.html"><![CDATA[<p>We are excited to welcome Dr. Meghali (Meg) Goswami as a Staff Scientist in the Rokita Lab at Children‚Äôs National Hospital (CNH) üéâ.
Meg joins us from the National Cancer Institute, where she became a leading expert in tumor immunology, translational research, and biomarker discovery for immuno-oncology therapies.</p>

<p>At NCI, Meg designed and led independent research focused on identifying immunological correlates of clinical response and survival in patients with solid tumors treated with investigational immunotherapies in phase I/II clinical trials. Her work leveraged high-dimensional flow cytometry, multi-omic analyses, and machine learning to uncover novel mechanisms of immune modulation and predictive biomarkers of treatment response.</p>

<p>Meg is passionate about integrating immunology, genomics, and data-driven discovery to develop immunotherapies for the treatment of cancer. She is also committed to building welcoming and inclusive communities that foster growth, collaborations, and friendships.</p>

<p>We‚Äôre thrilled to have you on the team, Meg, as we bring our computational discoveries to the bench, preclinically validating new therapeutic targets to advance precision medicine for children with brain tumors.
Welcome, Meg! üëè</p>]]></content><author><name>Jo Lynne Rokita</name></author><category term="team" /><summary type="html"><![CDATA[We are excited to welcome Dr. Meghali (Meg) Goswami as a Staff Scientist in the Rokita Lab at Children‚Äôs National Hospital (CNH) üéâ. Meg joins us from the National Cancer Institute, where she became a leading expert in tumor immunology, translational research, and biomarker discovery for immuno-oncology therapies.]]></summary></entry><entry><title type="html">Dr. Shang-Yang (Sam) Chen joins the Brain Tumor Institute Bioinformatics Core!</title><link href="https://rokitalab.com/2025/10/13/welcome-sam.html" rel="alternate" type="text/html" title="Dr. Shang-Yang (Sam) Chen joins the Brain Tumor Institute Bioinformatics Core!" /><published>2025-10-13T00:00:00+00:00</published><updated>2026-02-18T20:22:24+00:00</updated><id>https://rokitalab.com/2025/10/13/welcome-sam</id><content type="html" xml:base="https://rokitalab.com/2025/10/13/welcome-sam.html"><![CDATA[<p>We are excited to welcome Dr. Shang-Yang (Sam) Chen as a Bioinformatics Scientist in the Brain Tumor Institute Bioinformatics Core at Children‚Äôs National Hospital (CNH) üéâ.</p>

<p>Sam brings extensive experience in developing analytical workflows and integrating multi-omics datasets across industry and academic research settings. Most recently, he was a Bioinformatics Scientist at Dyno Therapeutics, where he designed and executed production-scale single-nucleus RNA-seq (snRNA-seq) quality control and analytical pipelines. He also led efforts to evaluate and validate machine guided AAV gene-therapy vectors, contributing directly to two successful product launches.</p>

<p>We‚Äôre thrilled to have Sam on board as we continue building a robust analytical infrastructure to drive discovery and precision medicine in pediatric research here at Children‚Äôs.
Welcome, Sam! üëè</p>]]></content><author><name>Jo Lynne Rokita</name></author><category term="team" /><summary type="html"><![CDATA[We are excited to welcome Dr. Shang-Yang (Sam) Chen as a Bioinformatics Scientist in the Brain Tumor Institute Bioinformatics Core at Children‚Äôs National Hospital (CNH) üéâ.]]></summary></entry><entry><title type="html">Dr. Corbett named as 2025 CCF NextGen Awardee!</title><link href="https://rokitalab.com/2025/08/07/corbett-ccf.html" rel="alternate" type="text/html" title="Dr. Corbett named as 2025 CCF NextGen Awardee!" /><published>2025-08-07T00:00:00+00:00</published><updated>2026-02-18T20:22:24+00:00</updated><id>https://rokitalab.com/2025/08/07/corbett-ccf</id><content type="html" xml:base="https://rokitalab.com/2025/08/07/corbett-ccf.html"><![CDATA[<p>We are thrilled to announce that Dr. Ryan Corbett has been selected as the 2025 NextGen Awardee by the Children‚Äôs Cancer Foundation for his grant entitled, ‚ÄúIdentification and functional targeting of alternative splice site usage in pediatric high-grade gliomas‚Äù.</p>

<p>The NextGen award is given annually to one young investigator dedicated to a long-term career in pediatric oncology research.
To read the CCF press release, see <a href="https://childrenscancerfoundation.org/2025awardees/">here</a></p>

<p>We are extra proud of this award, as it is the first Rokita Lab grant originating at Children‚Äôs National!
Thank you to Giant Food‚Äôs Pediatric Cancer Fundraising Campaign and the Children‚Äôs Cancer Foundation!</p>]]></content><author><name>Jo Lynne Rokita</name></author><category term="team" /><summary type="html"><![CDATA[We are thrilled to announce that Dr. Ryan Corbett has been selected as the 2025 NextGen Awardee by the Children‚Äôs Cancer Foundation for his grant entitled, ‚ÄúIdentification and functional targeting of alternative splice site usage in pediatric high-grade gliomas‚Äù.]]></summary></entry><entry><title type="html">Akhil Chada joins the Rokita Lab!</title><link href="https://rokitalab.com/2025/07/08/welcome-akhil.html" rel="alternate" type="text/html" title="Akhil Chada joins the Rokita Lab!" /><published>2025-07-08T00:00:00+00:00</published><updated>2026-02-18T20:22:24+00:00</updated><id>https://rokitalab.com/2025/07/08/welcome-akhil</id><content type="html" xml:base="https://rokitalab.com/2025/07/08/welcome-akhil.html"><![CDATA[<p>We are excited to welcome Akhil Chada to the Rokita Lab at Children‚Äôs National Hospital (CNH) üéâ.
Akhil joins us as a summer student and rising high school senior at James Madison High School in Fairfax County, Virginia. 
He brings expertise in several coding languages (Python, C++, R, and Java) and advanced mathematics.</p>

<p>Akhil is passionate about research at the intersection of math and biology, and is especially excited to apply these skills to the biomedical world to create real impact.</p>

<p>We‚Äôre thrilled to have Akhil with us as we delve into predictive algorithms to target RNA splicing in pediatric brain tumors!</p>

<p>Welcome, Akhil! üëè</p>]]></content><author><name>Jo Lynne Rokita</name></author><category term="team" /><summary type="html"><![CDATA[We are excited to welcome Akhil Chada to the Rokita Lab at Children‚Äôs National Hospital (CNH) üéâ. Akhil joins us as a summer student and rising high school senior at James Madison High School in Fairfax County, Virginia. He brings expertise in several coding languages (Python, C++, R, and Java) and advanced mathematics.]]></summary></entry><entry><title type="html">The Open Pediatric Cancer manuscript has been accepted for publication!</title><link href="https://rokitalab.com/2025/07/04/opc-paper-accepted.html" rel="alternate" type="text/html" title="The Open Pediatric Cancer manuscript has been accepted for publication!" /><published>2025-07-04T00:00:00+00:00</published><updated>2026-02-18T20:22:24+00:00</updated><id>https://rokitalab.com/2025/07/04/opc-paper-accepted</id><content type="html" xml:base="https://rokitalab.com/2025/07/04/opc-paper-accepted.html"><![CDATA[<p>We are excited to announce that our large, collaborative work on the Open Pediatric Cancer (OpenPedCan) Project has been accepted in GigaScience!
We are very grateful for the many researchers, clinicians, engineers, bioinformaticians, and investigators who have contributed to this work ‚Äì a true team effort!
Read the preprint <a href="https://www.biorxiv.org/content/10.1101/2024.07.09.599086v3">here</a>.</p>]]></content><author><name>Jo Lynne Rokita</name></author><category term="publication" /><summary type="html"><![CDATA[We are excited to announce that our large, collaborative work on the Open Pediatric Cancer (OpenPedCan) Project has been accepted in GigaScience! We are very grateful for the many researchers, clinicians, engineers, bioinformaticians, and investigators who have contributed to this work ‚Äì a true team effort! Read the preprint here.]]></summary></entry><entry><title type="html">New collaborative manuscript identifying and testing a splice event in the NRCAM gene has been accepted in Cell Reports!</title><link href="https://rokitalab.com/2025/07/01/nrcam-paper-accepted.html" rel="alternate" type="text/html" title="New collaborative manuscript identifying and testing a splice event in the NRCAM gene has been accepted in Cell Reports!" /><published>2025-07-01T00:00:00+00:00</published><updated>2026-02-18T20:22:24+00:00</updated><id>https://rokitalab.com/2025/07/01/nrcam-paper-accepted</id><content type="html" xml:base="https://rokitalab.com/2025/07/01/nrcam-paper-accepted.html"><![CDATA[<p>We were thrilled to contribute to the recently accepted manuscript, ‚Äú<em>NRCAM</em> variant defined by microexon skipping is an essential, antigenically distinct, and targetable surface proteoform in high-grade gliomas‚Äù, led by the lab of collaborator Dr. Andrei Thomas-Tikhonenko.
In this project, we identified a tumor-specific exon inclusion event in the <em>NRCAM</em> gene as a new therapeutic target.
Read the preprint <a href="https://www.biorxiv.org/content/10.1101/2025.01.09.631916v4">here</a>.</p>]]></content><author><name>Jo Lynne Rokita</name></author><category term="publication" /><summary type="html"><![CDATA[We were thrilled to contribute to the recently accepted manuscript, ‚ÄúNRCAM variant defined by microexon skipping is an essential, antigenically distinct, and targetable surface proteoform in high-grade gliomas‚Äù, led by the lab of collaborator Dr. Andrei Thomas-Tikhonenko. In this project, we identified a tumor-specific exon inclusion event in the NRCAM gene as a new therapeutic target. Read the preprint here.]]></summary></entry></feed>